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Abstract
Cutaneous leishmaniasis (CL), a vector-borne infectious disease caused by protozoan
parasites of the genus Leishmania, is one of the most important neglected infectious diseases
worldwide. Currently, 10 million people in 82 (mostly developing) countries are infected.
Those infected develop ulcerative skin lesions on exposed parts of the body, causing serious
disability and permanent scarring. All mice are susceptible to infection with Leishmania major,
however, the outcome of infection is different depending on the mouse strain. For example,
resistant C57BL/6 mice develop lesions, which like in humans, ultimately heal. In contrast,
lesions in susceptible BALB/c mice progressively worsen, ultimately resulting in mortality.
Resistance or susceptibility to Leishmania parasites is largely dependent on whether the host’s
CD4+ T cells develop into Th1 or Th2 effector cells, respectively. Resistant Th1 responses
are typically driven by cytokines like interleukin (IL)-12 and interferon- which promotes
healing and parasite clearance. In contrast, susceptible Th2 responses are marked by elevated
IL-4 production which inactivates the mechanisms of effective parasite clearance and
promotes disease progression through an ineffective, antibody-dominated humoral response.
IL-3 is a cytokine which promotes hematopoiesis and has the ability to act on numerous cell
lineages. In particular, IL-3 appears to have specialized functions in regards to the activation
of basophils. For example, IL-3 has been shown to be indispensable for increases in basophil
numbers in response to certain infections. Moreover, IL-3 has been shown to increase the
functional ability of basophils as IL-3-stimulated basophils are shown to secrete higher levels
of IL-4. IL-3 is primarily secreted by activated CD4+ effector T cells, the same cells which
are so influential in determining resistance and susceptibility to CL. However, the role of
IL-3 during the response to CL remains largely unknown. In the present study we show that
viii

infected mice genetically deficient in IL-3 (IL-3 -/- mice) develop smaller lesions, have a
lower parasite burdens, and express lower levels of B cells in draining lymph nodes as
compared to infected IL-3 +/+ mice. These data suggest IL-3 promotes susceptibility to
Leishmania infection and may play an important role in the development of a Th2 immune
response characteristic of susceptible BALB/c mice.

ix

Introduction
Cutaneous Leishmaniasis
Cutaneous Leishmaniasis (CL) is a vector-borne disease induced by multiple protozoan
species of the genus Leishmania. Transmission of this disease to a susceptible individual leads
to formation of ulcerated lesions in the dermis. Although lesions ultimately heal after a few
months, they often lead to secondary bacterial infections and can leave permanent scarring
and disfigurations. CL is a major threat to developing countries, although cases are reported
virtually worldwide. Overall, incidents of CL are concentrated in certain areas with over 90%
of all cases being reported in Afghanistan, Algeria, Iran, Iraq, Saudi Arabia, Syria, Brazil, and
Peru (1). The United States Department of Defense has recently heightened their interest in
this disease due to the deployment of U.S. troops into regions where leishmaniasis is
endemic (2). Exposure to Leishmania parasites in these regions has caused the number of
cases in the U.S. to increase to a level not seen since World War II (3). Currently, the Centers
for Disease Control and Prevention (CDC) reports Leishmania infection has become endemic
to 88 countries and causes 1.5 million new cases of CL each year. Although these numbers
are staggering, a true approximation of how many people this disease affects is impossible to
assess due to misdiagnosis, unreported cases, and insufficient communication with health
officials.
Leishmania major (L. major) is the causative agent of zoonotic CL. This protozoan parasite
has a digenetic life cycle made up of two developmental stages (4). The first is an
extracellular developmental stage located inside the sand fly vector where the parasite
assumes a spindle, flagellated morphology called a promastigote (Fig. 1). The second
developmental stage is intracellular and occurs primarily within host mammalian
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Figure 1 Microscopic image of flagellated L. major promastigotes in culture (1000 x
magnification).
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macrophages where parasites take on a smaller, non-flagellated ovoid shape referred to as an
amastigote (4, 6). The complete life cycle of Leishmania parasites is depicted in Figure 2.
The first stage of the parasite’s life cycle begins when the sand fly ingests macrophages
containing Leishmania amastigotes while feeding on a mammalian host. Once ingested,
infected macrophages travel to the midgut of the vector where they lyse, releasing the
amastigotes. Upon release, amastigotes transform to immature promastigotes termed
procyclics, whose surface is coated with lipophosphoglycan (LPG) (7). On immature
Leishmania promastigotes LPG molecules bind to insect gut epithelial cells (7) to provide
stability and allow for parasite maturation.
Leishmania parasites undergo development in the sand fly referred to as metacyclogenesis.
This maturation results in modifications to the LPG molecules causing them to elongate and
dissociate from gut epithelial cells rendering the parasites motile (7). Metacyclogenesis
produces mature parasites called metacyclic promastigotes, which are infective to humans
and other mammalian hosts (4). Infected sand flies inject these infective parasites into a new
host while taking a blood meal, thus beginning the second developmental stage in mammals.
Metacyclic promastigotes present within the mammalian hosts, quickly become engulfed
by macrophages (8). Parasites lose their flagellum inside these cells and transform to
amastigotes, the developmental stage in which they remain in the mammalian host (7).
Macrophages provide a venue for parasitic division which is accomplished by binary fission
(7). Replication ultimately lyses the host cell releasing amastigotes, which can infect other
phagocytes. Parasites are transmitted back to the sand fly when cells harboring amastigotes
are ingested from infected hosts during subsequent blood meals.

Innate immune response to L. major
Like other pathogens, L. major parasites are quickly confronted by effector
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Figure 2 Life cycle of Leishmania spp. showing developmental stages in both the
mammalian host and sand fly vector (8).
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mechanisms of the innate immune system such as complement proteins. The complement
system is comprised of numerous proteins that function to work against pathogens
immediately following infection. Normally, there are two primary outcomes for pathogens
which activate the complement system. First, complement can form a membrane attack
complex (MAC) which perforates the membranes of invading pathogens causing them to
degrade. Alternately, complement can opsonize pathogens allowing phagocytes expressing
complement receptors to bind and engulf these pathogens.
L. major metacyclic promastigotes, the infective stage for the mammalian host, are able to
avoid the detrimental effects of MAC formation by the alterations which occur during
metacyclogensis. In both non-infective promastigotes and metacyclic promastigotes, LPG
molecules are the primary binding site for complement proteins (9). However, as metacyclic
promastigote LPG molecules become elongated, they are able to prevent the complete
formation of MACs. This was demonstrated by Puentes et al. who noted effective MACs
formed on LPG molecules of non-infective promastigotes, whereas MACs could not form
on LPG molecules of metacyclic promastigotes (10). This finding suggests the longer LPG
molecules seen on metacyclic promastigotes may act as a physical barrier, inhibiting the
formation of intact MACs.
Another way L. major is able to avoid initial immune responses is through their ability to
hide within cells such as macrophages, which are typically responsible for eliminating
pathogens. Macrophage uptake of parasites is thought to occur in a number of different
ways. For example, Russell et al. (1988) demonstrated phagocytosis of Leishmania parasites
occurred through binding of complement receptor CR3 on macrophages directly to gp63, a
major surface glycoprotein expressed on promastigotes (11). Additionally, macrophage
uptake of Leishmania promastigotes has been shown to occur indirectly by complement
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receptors CR1 and CR3 binding C3b and iC3b opsonized LPG molecules, respectively (9,
12). Collectively, these studies suggest macrophage internalization of Leishmania
promastigotes can happen in a number of different ways and could be dependent upon
complement proteins. Once located intracellularly, L. major must use a number of
specializations to survive in the hostile environment of macrophages.
When promastigotes are engulfed, they become surrounded by the plasma membrane of
macrophages forming a compartment called a phagosome. Lysosomes inside the host
macrophage then fuse with phagosomes to form parasitophorous vacuoles (PVs), the site
where promastigotes develop into amastigotes (13). Survival at this stage requires that
parasites be able to withstand the harsh, protease rich environments of PVs that can reach
pH values as low as 4.74 (14). It has been shown that parasites express a variety of molecules
which aid their survival in this environment (15, 16). However, the adjustments made by
amastigotes to avoid destruction in PVs are not fully understood and will require further
investigation. Eliciting these mechanisms may reveal important targets for therapeutics in the
fight against CL.
Engulfment of Leishmania parasites induces cytokine and chemokine production by cells
at the site of infection. Released cytokines and chemokines recruit other immune cells to the
site of infection. As immune cells begin trafficking to the infection site, antigen presenting
cells (APCs), such as skin dendritic cells (a.k.a. Langerhans cells), become infected and then
proceed to the draining lymph nodes (LNs) of the host (17). Dendritic cells then initiate
adaptive immune responses by presenting the parasites to T helper (Th) lymphocytes
expressing T cell receptors (TCRs) specific for Leishmania antigens. These TCRs were found
to primarily recognize a particular Leishmania-peptide sequence which was designated LACK
(Leishmania homolog of the receptor for activated C Kinase) (18). Once Leishmania-specific
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Th lymphocytes become primed, they differentiate into subpopulations of effector cells
which initiate adaptive immune responses against the parasites.

T helper 1/T helper 2 cell paradigm
A pivotal point in the immune response is when CD4+ T helper cells differentiate into
sub-populations such as T helper 1 (Th1) and T helper 2 (Th2) (Fig. 3). Naive CD4+ T cells
become activated in lymphoid tissue by APCs expressing antigens in the context of a
molecule known as the Major Histocompatibility Complex (MHC) Class II. APCs such as
dendritic cells, located at the initial site of infection, take up pathogens and process their
antigens by the endocytic pathway. This ultimately results in the expression of the pathogen’s
antigenic peptides on the surface of APCs. During antigen processing, APCs make their way
to secondary lymphoid tissues such as the draining LNs and spleen where they present
pathogen derived antigenic peptides to naive CD4+ T cells. If CD4+ cells have TCRs specific
for the particular antigen being presented, they will undergo clonal expansion and
differentiation into effector cell subsets such as Th1 and Th2 cells. Th1 and Th2 cell
differentiation is regulated by cytokines and each subset of cells has distinct effector
mechanisms.
Whether a naive T helper cell becomes a Th1 or Th2 cell primarily depends on the type
of cytokines present in the cellular environment during the early stages of infection. If
secondary lymphoid tissue is rich in cytokines like interleukin-12 (IL-12) and interferonIFN- ), T cells will predominately develop into Th1 cells (19). After differentiation, CD4+
Th1 cells can exit lymphoid tissue and activate CD8+ T cells, macrophages, and other
phagocytic cells which are effective at eliminating intracellular invaders (20-22). For example,
Th1 cells are able to activate macrophages causing them to boost production of nitric oxide
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Figure 3 Schematic representation of naive CD4+ T helper cells differentiating into
subpopulations in response to different cytokines (Figure modified from Mesquita etal.
(23)).
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and its derivatives which results in a hostile intracellular environment for pathogens (23).
In contrast, naive CD4+ T cells in the presence of cytokines such as IL-4 and IL-10
develop into Th2 cells (19). CD4+ Th2 cells primarily function to stimulate activated B cells
to further differentiate into antibody (Ab) secreting plasma cells, thus leading to a humoraldominated immune response. Th2 polarized immunity has been shown to effectively combat
extra cellular pathogens such as helminths (24) and is associated with promoting the
pathology seen in asthma and other IgE-dependent allergic diseases (25).

Th1 and Th2 lymphocytes in murine CL
Th2 immunity produces responses which are primarily effective against extracellular
pathogens while Th1 immunity is better equipped for eliminating intracellular pathogens.
Because Leishmania parasites remain intracellular within the mammalian host, to clear this
infection a host must mount an INF-

and IL-12-driven Th1 response. There are well-

established mouse models used to study host immune responses against CL. The most
popular of these models utilizes genetically susceptible BALB/c mice and resistant C57BL/6
mice (26).
In susceptible strains such as BALB/c, Leishmania infection induces Th2 type immunity
resulting in elevated Ab levels, high IL-4, and low IFN- expression (21) resulting in
progressive disease and parasite visceralization which ultimately becomes lethal to BALB/c
mice (27). In contrast, resistant C57BL/6 mice mount a Th1 polarized immune response to
Leishmania infection that is characterized by modest Ab levels, high IFN- , and low IL-4
expression (27). This type of immunity upregulates the production of reactive oxygen species
by Leishmania-infected macrophages, which impedes parasite growth and results in disease
clearance (28).
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Direct evidence for the necessity of a Th1 response in clearing Leishamania infection has
been shown by using purified Th1 and Th2 cells specific for Leishmania antigen (Ag) and
transferring them into susceptible BALB/c mice prior to infection (29). These studies were
able to show that L. major-infected mice which were passively immunized with L. majorspecific Th2 cells displayed accelerated lesion development compared to control mice.
However, susceptible BALB/c mice were protected from infection following passive
immunization with L. major-specific Th1 cells.

Interleukin-3
Interleukin-3 (IL-3) is a cytokine primarily secreted by CD4+ T cells which have become
activated by antigens during infection (30). This cytokine is a 28-kDa glycoprotein comprised
of 133 amino acids and has been implicated in the expansion of hematopoietic progenitor
cells (31). This expansion leads to increased production of cells such as neutrophils,
macrophages, eosinophils, erythrocytes, megakaryocytes, dendritic cells, mast cells and
basophils (31). In addition to expanding the population of its target cells, IL-3 also appears
capable of increasing the functional ability of these cells, which affects the levels of secretory
product expressed by target cells.
Once secreted, IL-3 binds to target cells expressing IL-3 receptors composed of two
subunits. The first receptor component is an alpha subunit (IL-3R ) which is specific for
IL-3. The second receptor component is referred to as the beta common (βc) subunit, which
is shared by the receptors for IL-3, IL-5, and granulocyte macrophage-colony stimulating
gactor (GM-CSF) (32). Both the

and βc subunits are required for IL-3 to optimally activate

target cells (33). However, it is important to note that IL-3 can utilize an additional βc
subunit called βcIL-3, which is not shared among IL-5 and GM-CSF receptors (34).
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Therefore, in mice which are lacking a functional βc subunit, IL-3 can remain functional by
binding IL-3R and βcIL-3 subunits.
The process of IL-3 activation begins when the cytokine associates with an IL-3-specific
subunit. This interaction produces a low affinity binding complex which is not sufficient
for activating the signaling pathways which stimulate target cells. However, in the presence
of the βc or βcIL-3 subunits, the affinity of IL-3 for the receptor increases causing the
receptors to aggregate and transmit signals to internal regions of cells (35). Aggregated βc (or
βcIL-3) subunits allow enzymes located in the cytoplasm of target cells to phosphorylate these
receptors, a mechanism required for IL-3 signaling (36).
Once neighboring βc subunits aggregate, they interact with tyrosine kinases known as
Janus kinases (JAKs). Although there are a number of JAKs proteins which have been
identified, JAK-2 appears to dominate in the activation of IL-3 receptors (37). Activity from
JAK-2 results in the phosphorylation of multiple tyrosine residues, which converts them to
binding sites for intracellular signaling proteins (38, 39). The most important intracellular
signaling proteins for IL-3 activation of target cells are proteins called signal transducers and
activators of transcription (STATs) (40). STATs dock to the phosphorylated tyrosine
residues and transmit signals to the cell’s nucleus activating transcription of particular genes
(33). Activating transcription pathways results in the stimulation of target cells and leads to
proliferation and increased cellular function.

IL-3 and Leishmania infection
There have only been a limited number of studies suggesting that IL-3 functions during
immune responses to Leishmania. Lelchuk et al. (1988) suggested a role for IL-3 in
exacerbating CL following experiments which used spleen cells from genetically resistant and
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susceptible mice strains (41). These researchers showed cells isolated from resistant
C57BL/6 mice generated lower levels of IL-3 when exposed to Leishmania antigens
compared to cells isolated from susceptible BALB/c mice. These studies suggest the
presence of IL-3 may be at least partially responsible for susceptible mice strains mounting
an ineffective immune response to Leishmania parasites.
Other investigators evaluating IL-3 in CL include Feng et al. (1988) who experimentally
infected footpads of susceptible BALB/c mice with L. major (42). After infection,
investigators injected recombinant IL-3 into the mice and then assessed lesion sizes. They
found that infected mice that were treated with IL-3 had larger lesions compared to mice
treated with Phosphate Buffered Saline (PBS) as a control. These findings were supported by
Saha et al. (1999) who also experimented with L. major infected mice (43). These investigators
injected mice with Leishmania parasites and then treated them with neutralizing antibodies
against murine IL-3. They found disease severity was markedly reduced in mice given antiIL-3 antibodies, which in accordance with the above studies, indicated IL-3 promotes
susceptibility to Leishmania infection in BALB/c mice. Collectively, the results from these
experiments suggest susceptibility to CL is influenced by IL-3.

Basophils
IL-3 production can influence the number and activational status of most hematopoietic
cells, especially basophils. Basophils are granulocytes that compose a very small portion of
peripheral white blood cell (WBC) populations during homeostasis, representing less than
1% of circulating leukocytes (44). Due to meager levels of these cells, it has been difficult to
study the functions of basophils in vivo. However, a number of recent studies have
underscored the importance of basophils during the immune response.
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Hematopoietic progenitors in bone marrow produce granulocytes such as basophils (5).
In response to certain infections, basophils are recruited to the site of invasion and
participate in inflammatory attacks on pathogens (45). Basophils express high levels of
Fc RI, the receptor for Fc regions of IgE antibodies. Cross-linkage of antigen-specific IgE
on the surface of basophils activates the cell causing degranulation and the release of
preformed mediators such as histamine. Activation also causes basophils to produce a
number of cytokines such as IL-4 (46).
There has been a renewed interest in basophils and their role in immunity because of
their ability to produce IL-4 (47, 48). Pioneers in basophil biology have recently determined
that basophil derived IL-4 is especially important in Th2 differentiation. For example, Sokol
et al. (2008) showed basophils exposed to protease allergens can travel to the draining lymph
node and provide the initial signal to promote Th2 differentiation in vivo, likely through their
production of IL-4 and other similarly acting cytokines (49). In fact, mounting evidence
indicates basophils and their production of IL-4 are directly responsible for producing Th2
responses (44, 46, 48, 50, 51).
Recent studies indicate basophils can promote Th2 immune responses independent of
IL-4 production alone. For example, investigators have demonstrated that basophils, rather
than dendritic cells, can serve as APCs and provide the essential cytokines which drive Th2
responses to the cysteine protease papain (49). Two additional studies have also suggested
basophils can function as APCs (52, 53), which until recently, was an unknown function of
this cell.
The function of IgE cross-linked basophils can be increased by a variety of other stimuli
including cytokines (54, 55), proteases (49), helminth products (56, 57), and possibly toll-like
receptors ligands and complement proteins (58). However, the most powerful stimulus
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which synergizes with activated basophils appears to be IL-3 (46), which has been shown to
be indispensable for increased basophil functionality and proliferation during certain
infections. For instance, Lantz et al. (1998) showed at physiological conditions basophil levels
in IL-3 +/+ and IL-3 -/- mice were approximately equal indicating IL-3 is not required for
producing baseline levels of basophils. However, IL-3 +/+ mice produce markedly higher
levels of basophils in bone marrow and blood compared to IL-3 -/- mice following infection
with the nematodes Stronglyoides venezuelensis and Nippostrongylus brasiliensis (24, 59).
Importantly, these investigators also show basophil levels in nematode-infected IL-3 -/mice were essentially the same as basophil levels seen in uninfected mice. These studies
indicate that, although IL-3 is not required for producing baseline levels of basophils, it is
essential for practically all increases in basophils in response to gastrointestinal nematodes.
More recently, Lantz et al. (2008) showed that IL-3 stimulation induces activated
basophils to upregulate their production of IL-4 (24). As stated above, IL-4 is the primary
cytokine responsible for driving Th2 development, the susceptible response to CL.
Nevertheless, it has not been determined if IL-3 stimulated-basophil-derived IL-4 is
responsible for Th2 responses characteristic of L. major-infected susceptible BALB/c mice.

Project goals
A number of studies have reported that IL-3 production correlates with susceptibility of
BALB/c mice to infection with L. major and that IL-3 can promote basophil expansion and
enhance basophil cytokine production. However, the precise role of IL-3, and IL-4producing basophils, in CL has yet to be addressed. We propose to take advantage of
exciting opportunities to analyze the role of IL-3 and basophils in a mouse model of CL.
Specifically, we will use BALB/c IL-3-deficient (IL-3 -/-) mice and their wild type
counterparts (IL-3 +/+ mice), to test two major but related hypotheses: 1) that endogenous
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IL-3 significantly promotes the susceptibility of BALB/c mice to Leishmania major infection
as reflected by measures of lesion size and parasite burden, and 2) that Leishmania major
infection induces IL-3-dependent increases in basophils.

The specific aims of this project are as follows: (start revision Rajeev here)
Aim 1 - Assess the extent to which IL-3 influences the course and outcome of
disease in Leishmania major-infected BALB/c mice. We used BALB/c IL-3 -/and +/+ mice infected with different inocula of L. major to test the hypothesis that
endogenous IL-3 contributes to the development of cutaneous lesions and the high
parasite load characteristic of susceptible BALB/c mice.

Aim 2 - Assess the extent to which basophils influence disease susceptibility in
Leishmania major-infected BALB/c mice. We employed IL-3 +/+ mice to test the
hypotheses: 1) that L. major induces increases in basophil numbers in bone marrow, and
2) that L. major infection and associated IL-3 production induces basophil migration to
the draining lymph nodes in IL-3 +/+ mice.

Materials and Methods
Mice
The production of IL-3 -/- BALB/c mice, and many of the phenotypic characteristics of
these mice, has been described in detail (60-62) and were graciously provided by Dr. Chris
Lantz. Wild type BALB/c mice were purchased from Jackson laboratories and used as IL-3
+/+ mice. For the present studies, mice were 8-12 weeks of age at the beginning of the
experiment. For individual experiments, IL-3 +/+ and IL-3 -/- mice of the same sex and
approximately the same age were used (n = 3 – 5) and experiments were repeated up to
three times. The genotypes of randomly selected mice were verified by PCR essentially as
previously described (61) (Appendix Fig. 14). Mice were housed in microisolater cages in the
Department of Biology’s animal facility under a 12h light-dark cycle and were maintained
and used in accordance with James Madison University’s Institutional Animal Care
guidelines.

Parasites and infection
Leishmania major LmFV1, a virulent clonal derivative of the Friedlin line
(MHOM/IL/80/Friedlin) was kindly provided by Dr. David Sacks (National Institutes of
Health). L. major promastigotes were cultured in medium 199 containing Hank’s salts and Lglutamine (M-199) (Sigma-Aldrich) with 0.1 mM adenine (in 50 mM HEPES), 100 U/mL
Penicillin, 100 g/mL Streptomycin (Sigma), 5 g/mL hemin (in 50% (v/v)
triethanolamine) (Fluka, Aldrich), and 20% heat inactivated fetal calf serum (FCS) at a pH of
approximately 7.15 (cM-199).
cM-199 facilitates the process of metacyclogenesis allowing parasites to develop from a
dividing, noninfective stage to a nondividing, infective stage (Appendix Fig. 15). During the
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initial days of culture (days 1-2), parasites grow at an exponential rate and are said to be in
logarithmic phase until day 3-4 when growth starts to plateau. Once growth levels off,
parasites cultures enter the stationary phase, which tends to yield a sufficient number of
metacyclic promastigotes for infecting mice (Appendix Fig. 16).
Infective stage metacyclic promastigotes of L. major were isolated from stationary
cultures (4-6 day old) using negative selection with peanut agglutinin (Vector Laboratory
Inc.) as previously described (63). 1.0 x 104- 2.5 x 104 infective stage parasites in 10 or 15 μL
were then injected into the dermis of either the right or left ear of BALB/c mice (Appendix
Fig. 17). The uninfected ear was used as a control and injected with an equal volume of
sterile Phosphate Buffered Saline (PBS). Images of uninfected and L. major-infected ears are
shown in Appendix Figure 18. All injections were given with 31 gauge hypodermic needles
fitted on a 0.3 mL syringes.
The course of L. major infection was monitored at weekly intervals by measuring the
thickness of infected ears with a Mitutoyo digital micrometer. Lesion sizes were expressed as
the change in thickness by measuring the infected ears and subtracting the thickness of the
ear prior to infection (baseline). Photographs were also taken of representative mice from
IL-3 +/+ and IL-3 -/- groups at different time points during infection.

Parasite Quantification
To determine parasite load in L. major infected mice, a serial dilution assay was
performed in vitro essentially as previously described (63). Infected ear samples were collected
at different time points post-infection and weighed. Using sterile forceps, infected ears were
separated into ventral and dorsal sheets and placed into sterile 35mm petri dishes containing
Dulbecco’s Modified Eagle Medium (DMEM), 100 U/mL penicillin, 100 µg/mL
streptomycin, and 0.5 mg/mL Liberase TL (Roche). Infected ear sheets were digested at
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37°C at 5% CO2 for approximately three hours. After incubation, ear sheets were removed
and placed in a clean sterile 35 mm petri dish and cut into small pieces using a sterile scalpel.
Ear tissues were then transferred to a microfuge tube containing 100 µL CM-199 and
homogenized with a Teflon coated pestle. After homogenization, 0.9 mL of CM-199 was
added and the homogenates were strained twice through a 70 µm cell strainer. A 125 µL
sample of the resulting single cell suspension was added to one well of a 96-well plate
containing 250 µL of cM-199, resulting in a 1:3 dilution. Serial dilutions (1:3) were then
performed on the 96-well plate to extinction. Each dilution was then plated in duplicate in
96-well plates containing slanted blood agar and incubated for 7 days at 26°C. After
incubation, each dilution was monitored for parasite growth via an inverted microscope. The
reciprocal of the largest dilution at which promastigotes could be detected in duplicate
samples was then averaged and reported for each mouse.
Parasitic load was also determined using quantitative, relative real-time PCR to detect
different levels of L. major DNA in IL-3 +/+ and IL-3 -/- ears essentially as previously
described (64). Briefly, infected and uninfected ears of IL-3 +/+ and IL-3 -/- mice were
collected, snap frozen in liquid nitrogen, and the DNA extracted using GenElute
Mammalian Genomic DNA Miniprep Kit (Sigma-Aldrich). Each sample of extracted DNA
(10 ng) was subjected to real-time PCR in triplicate using Platinum SYBR Green qPCR
SuperMix-UDG cocktail (invitrogen) essentially according to manufacturer’s protocol and a
Bio-Rad CFX96 Real-Time PCR Detection System. Amplification of Leishmania-specific
DNA was performed using the previously described primers, forward: 5CCTATTTTACACCAACCCCCAGT-3 (JW11); and reverse: 5-GGGTAGGGGCGTTC
TGCGAAA-3 (JW12) (Intergrated DNA Technologies) (64, 65). DNA was initially
denatured for a single cycle at 95°C. After the initial denaturation step, DNA was denatured
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at 95°C for 5 sec followed by a combined annealing/extension step at 58°C for 5 sec.
Denaturation and annealing/extension steps were repeated 39 times and fluorescence
intensity was measured at the end of each cycle. Relative amounts of parasite DNA present
in L. major- infected IL-3 +/+ and IL-3 -/- ears is reported as the threshold cycle (CT), at
which there was a positive signal for parasite DNA over the background. Samples from
uninfected IL-3 +/+ and IL-3 -/- mice ears were used as controls to ensure primers were
specific for L. major DNA.

Quantification of lymphocytes by flow cytometry
LN cells were collected from L. major infected IL-3 +/+ and IL-3 -/- mice to identify
CD4+ and B cell populations using an Accui C6 flow cytometer. All samples were treated
with purified anti-mouse monoclonal antibody (mAb) CD16/CD32 (clone 2.4G2) (10
g/mL) for 10 min to prevent antibody binding to Fc RII/III prior to staining cells. All
staining and incubation steps were performed at 4 °C. To identify CD4+ cells, samples were
stained with Fluorescein isothiocyanate (FITC) anti-mouse CD4 mAb (clone L3T4)
(5 g/mL). To identify B cell populations, LN cells were stained with and Phycoerythrin
(PE) anti-mouse CD45R mAb (clone B220) (4 g/mL). Prior to examining stained cells,
lymphocytes were initially identified by their characteristic forward (FSC) and side scatter
(SSC) properties.

Quantification of basophils by flow cytometry
LN and bone marrow samples were also evaluated via flow cytometry for the presence
of basophils. Bone marrow-derived basophils were identified based on their expression of
Fc RI by incubation with mouse IgE (30 min) followed by staining with FITC anti-mouse
IgE mAb (clone R35-72) (10 g/mL). Because B cells also express low affinity IgE Fc
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receptors (CD23), they were distinguished from basophils by staining with PE CD45R mAb
(clone B220) (4 g/mL). To identify basophils in LN samples, cells were first treated with
purified anti-mouse CD23 mAb (clone B3B4) to block low affinity Fc IgE receptors on B
cells. Samples were then incubated with ascites IgE (30 min) prior to staining with FITC
anti-mouse IgE mAb (clone R35-72) (10 g/mL) and PE anti-mouse CD49b mAb (clone
DX5) (4 g/mL). All flow cytometric data was analyzed on the Accuri C6 using CFLOW
Plus Software.

Statistical analysis
Values of p ≤ 0.05 were considered statistically significant as determined by an unpaired,
two tailed Student’s t test unless otherwise noted.

Results
IL-3 influences cutaneous lesion development in L. major-infected mice
To evaluate the functions of IL-3 in CL, IL-3 +/+ and IL-3 -/- mice were infected with
L. major to determine the ability of this cytokine to influence the size of developing lesions.
The thickness of L. major-infected IL-3 +/+ and IL-3 -/- mice ears were measured weekly
over a course of ten weeks. As expected, BALB/c IL-3 +/+ mice developed noticeable
lesions which appeared approximately three weeks post-infection. By four weeks, IL-3 +/+
lesions were readily apparent and displayed visual inflammation accompanied by ulceration
that persisted throughout the 10 week infection. Interestingly, IL-3 -/- mice developed
lesions which were barely detectable at three weeks and inflammation was not noticeable
until approximately six weeks post-infection. Overall, IL-3 +/+ mice developed significantly
thicker ears compared to IL-3 -/- mice throughout the 10 week infection (Fig. 4). The
degree of inflammation was also visually different in IL-3 +/+ and IL-3 -/- mice (Fig. 5).
Lesion size has been shown to be dependent on dose of parasites used to infect mice
(66-68). Therefore, infections were repeated with lower parasite inocula (1.5 x 104 or 1.0 x
104) to determine if differences in lesions among IL-3 +/+ and IL-3 -/- mice could still be
observed when infecting with fewer parasites. Comparison of lesion size between the two
genotypes showed IL-3 +/+ mice infected with 1.5 x 104 metacyclic promastigotes displayed
lesions which were thicker compared to similarly infected IL-3 -/- mice (Fig. 6A). Likewise,
similar differences were seen in lesion thickness when mice were infected with 1.0 x 104
parasites (Fig. 6B). Regardless of infectious dose, IL-3 +/+ mice lesions displayed an
advanced level of ulceration and appeared to be more inflamed compared to IL-3 -/- mice at
similar time points of infection. Similar to mice shown in Fig. 4, statistically significant
differences in lesion size became apparent at three to four weeks post-infection. This
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Figure 4 Infected ear thickness from IL-3 +/+ and IL-3 -/- mice. Both BALB/c IL-3
+/+ and IL-3 -/- mice were infected into the ear dermis with 2.0x104 metacyclic
promastigotes in 15uL inoculums. Contralateral ears were injected with 15uL of sterile
PBS. Thickness of infected ears were measured weekly for 10 weeks. Data represent the
mean ± SEM (n = 4 mice/group). Statistical significance was determined by an unpaired,
two tailed student’s t-test. P value was ≤ 0.05 at weeks 4 – 9. P value = 0.056 at 10 weeks.
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Figure 5 L. major infected IL-3 +/+ (A) and IL-3 -/- (B) mice 6 weeks post-infection
with 2.0x105 metacyclic promastigotes.
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Figure 6 Lesion development in BALB/c IL-3 +/+ and IL-3 -/- mice infected with 1.5
x 104 (A) or 1.0 x 104 (B) infective stage L. major metacyclic promastigotes. L. major
promastigotes were injected subcutaneously into the dermis of either the right or left ear.
The contralateral ear was injected with equal amounts of sterile PBS. Data represent
mean ± SEM (n = 4 or 5 mice/group). Statistical significance was determined at four
weeks post-infection by an unpaired, two-tailed Student’s t-test. Asterisk (*) indicates a p
value ≤ 0.05 versus corresponding values for mice of the other genotype.
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suggests that irrespective of infectious dose, IL-3 influences the development of L. majorinduced cutaneous lesions.
These data indicate IL-3 influences lesion size starting at three weeks post-infection and
that these differences are maintained as long as 10 weeks post-infection. We next wanted to
see if the effects of IL-3 were evident at greater than 10 weeks post-infection. For this
experiment, mice were infected with 1.0x104 parasites. Fewer metacyclic promastigotes were
used in this experiment because in BALB/c mice given higher doses, L. major becomes lethal
through its ability to visceralize and infect other organs such as the spleen and liver (26).
These studies found that differences seen in lesion sizes from four to 10 weeks postinfection could also be detected in mice infected for four months (Fig. 7). In fact, lesions in
IL-3 +/+ mice were on average twice the size of those observed in IL-3 -/- mice. Consistent
with data from shorter-term experiments, IL-3 +/+ mice appeared to have more necrosis
and inflammation at the site of infection. Collectively, these data suggests IL-3 can influence
the degree of lesion development at both high and low parasite doses and continues to affect
lesion inflammation in more chronically infected mice.
Surprisingly, two of the four IL-3 -/- mice infected for four months appeared to clear
the infection. These two mice had significant lesions at four weeks post-infection. However,
by four months post-infection lesion size had essentially returned to baseline levels and very
little inflammation could be detected visually (Fig. 8). The ability of some IL-3-/- mice to
apparently clear their infection is an exciting finding because it may suggest in the absence of
IL-3, mice possibly develop a more protective Th1-dominated immune response.

IL-3 influences parasitic load L. major-infected mice
Past research has shown lesion size in L. major-infected mice does not always correlate
with numbers of parasites present in infected tissue. For example, some investigators have
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Figure 7 Ear thickness of uninfected and L.major-infected BALB/c IL-3 +/+ and IL-3
-/- mice. Measurements were taken four months post-infection with 1.0x104 metacyclic
promastigotes in 10uL inoculums. Data represent mean ± SEM (n = 4 mice/group).
Statistical significance was determined by an unpaired, two tailed Student’s t-test.
Double asterisk (**) indicates a p value ≤ 0.01 compared to mice of the other genotype.
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Figure 8 Image of IL-3 -/- mouse ear four months following infection with 1.0 x 104
metacyclic promastigotes. Minimal inflammation was detectable in these infected ears
which appeared visually similar to control uninfected ears (see Fig. 18).
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reported increased lesion size is a function of increased parasite load (69). However, others
have shown maximum parasite burden occurs prior to the time infected mice present
greatest lesion size (70). Therefore, it was next determined if differences seen in lesion sizes
of IL-3 +/+ and IL-3 -/- mice correlated with differences in parasite burden.
The standard procedure for estimating parasite load during L. major infection is a cell
culture assay in which serial dilutions of infected ear tissue are cultured in blood agar.
However, new protocols which utilize real-time PCR (qPCR) and the ability to identify L.
major DNA have been described which are less laborious and could prove to be much more
accurate. Therefore, both limited dilution culture of parasites from infected tissue and
relative qPCR were used to estimate parasite burden in infected groups of mice.
Limited dilution culture assays indicated IL-3 +/+ mice had substantially more L. major
parasites per milligram of tissue at four weeks post-infection compared to similarly infected
IL-3 -/- mice (Fig. 9). Furthermore, qPCR results indicated samples from L. major-infected
IL-3 +/+ mice had significantly lower CT values four months post-infection than IL-3 -/mice (Fig. 10). CT values indicate the cycle at which a positive signal for target DNA is
detected. Therefore, lower CT values in IL-3 +/+ mice indicates they had more L. major
DNA at the infection site, suggesting chronically infected IL-3 +/+ mice have higher
parasite burdens compared to similarly infected IL-3 -/- mice. There was also a general trend
in these experiments showing mice which had the thickest lesions also had the highest
concentration of parasites at the site of infection, regardless of genotype. This suggests there
is a positive correlation between lesion thickness and concentration of parasites in infected
tissue. Additionally, the two IL-3 -/- mice that appeared to clear the chronic infection
showed only slightly higher levels of L. major DNA compared to uninfected controls.

IL-3 influences lymphocyte populations in L. major-infected mice
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Figure 9 Number of parasites per mg of infected ear tissue. L. major-infected BALB/c
IL-3 +/+ and IL-3 -/- mice ears were collected and weighed 4 weeks following infection
with 1.0x104 metacyclic promastigotes. Cells harboring parasites were extracted from
infected ears and serially diluted as described in the materials and methods. The reciprocal
of the largest dilution at which promastigotes could be detected in duplicate assays was
then averaged and reported as the mean ± SEM (n=5 mice/group). Statistical significance
was determined by an unpaired, two tailed Student’s t-test. p value = 0.0503 for infected
IL-3 +/+ and IL-3 -/- mice. The data shown are from a single experiment that is
representative of two separate experiments.

Number of parasites/mg tissue

38

1.5 10 4

1.0 10 4

5.0 10 3

0
IL-3 +/+

IL-3 -/-

39

Figure 10 Parasite load in L. major-infected BALB/c IL-3 +/+ and IL-3 -/- mice ears 4
months following infection with 1.0x104 metacyclic promastigotes. Infected ears (n = 4
mice/group) were collected and analyzed for L. major DNA via qPCR as described in the
materials and methods. One uninfected ear from each group was also collected to serve
as a negative control. Data represents mean threshold cycle (CT) at which each sample
was positive for L. major DNA. Statistical significance was determined by an unpaired,
two tailed Student’s t-test. Asterisk (*) indicates a p value ≤ 0.05 versus corresponding
values for mice of the other genotype.
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Generation of adaptive immune responses against Leishmania parasites coincides with the
expansion of certain cell populations in the LNs of infected organisms. The sub-populations
of lymphocytes which undergo expansion influence if a host is resistant or susceptible to this
infection. Therefore, the effect of IL-3 on lymphocyte populations was monitored in LNs of
uninfected and L. major-infected IL-3 +/+ and IL-3 -/- mice. Levels of CD4+ T cells and B
cells were identified in auricular LNs by flow cytometry from L. major-infected mice at four
weeks post-infection and in uninfected mice.
These analyses revealed essentially no difference in the levels of CD4+ T cells and B cells
in uninfected IL-3 +/+ and IL-3 -/- mice. However, four weeks after infection with 1.0 x
104 metacyclic promastigotes, IL-3 +/+ mice had a significantly higher percentage of B cells
than similarly infected IL-3 -/- mice (Fig. 11). Interestingly, LNs from IL-3 +/+ mice also
contained a substantially lower percentage of CD4+ T cells compared to IL-3 -/- mice (Fig.
11). These data indicate IL-3 may promote the expansion of B cells and inhibit T helper cell
development. This effect on B and T cells indicates that IL-3 could be abrogating a
protective immune response, although it is unclear if this effect is direct or indirect.

IL-3 regulation of basophil development in L. major-infected mice
Activated basophils have gained interest from investigators studying the immune system
because of their recently discovered ability to promote TH2 responses by producing IL-4 (50,
71). Furthermore, studies have demonstrated IL-3-stimulated basophils can undergo
increased proliferation and IL-4 production in response to certain infections (24, 59). As
previously mentioned, susceptibility to CL is promoted by IL-4-driven Th2 host responses.
However, to our knowledge no one has examined the effects of IL-3 or basophils during
Leishmania infection. Therefore, basophil levels were monitored in infected mice to see if
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Figure 11 Percent of CD4+ T cells and B cells in LNs of uninfected and L. major-infected
mice (A). Uninfected and L. major-infected LNs were collected from IL-3 +/+ and
IL-3 -/- mice at 4 weeks post-infection with 1.0x104 metacyclic promastigotes and
analyzed via flow cytometry. (B, C) Dot plots representative of data from Fig. 3.10A
showing CD4+ and B220+ cells from uninfected (B) (n = 3) and infected (C) (n = 5) LN
populations. The data shown are from a single experiment that is representative of two
separate experiments. Statistical significance shown in Fig 3.10A was determined by an
unpaired, two tailed Student’s t-test. Asterisk (*) indicates a p value ≤ 0.05 versus
corresponding values for mice of the other genotype.
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increases could be detected in response to L. major parasites. Initially, these studies were only
performed with IL-3 +/+ mice because increases in basophils were not expected in IL-3 -/mice (24, 50). Therefore, if no increases in basophil levels were detected in IL-3 +/+ mice, it
is unlikely that increases would be seen in IL-3 -/- mice.
As expected, results from these experiments indicate basophil numbers in bone marrow
samples from uninfected BALB/c IL-3 +/+ mice were less than 1 percent, typical for mice
under baseline physiological conditions (59). Interestingly, after infecting mice with 2.0 x 104
metacyclic promastigotes, basophil levels in the bone marrow remained below one percent
and were essentially the same as compared to uninfected mice. This experiment indicated
infection with a relatively high dose of Leishmania parasites induces no increases in basophil
numbers in BALB/c mice at 5 weeks post-infection (Fig. 12).
Basophil activity was also evaluated in other tissues of L. major-infected BALB/c IL-3
+/+ mice. LNs, which are typically devoid of basophils, were studied because any observed
increase in basophil numbers might suggest they migrate to lymphoid tissue and contribute
to IL-4 dependent immune responses. Draining LNs were collected from mice infected with
1.0 x 104 metacyclic at days four, nine, and four weeks post-infection and basophils were
detected by flow cytometry. However, detectable levels of basophils were not observed in
LN samples from BALB/c IL-3 +/+ mice at any time point evaluated (Fig. 13); suggesting
Leishmania infection may not induce basophil proliferation and/or basophil migration to
LNs.
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Figure 12 Basophil levels in uninfected and infected BALB/c IL-3 +/+ mice injected
with 2.0x104 metacyclic promastigotes (A). Bone marrow samples were collected 5 weeks
post-infection from uninfected (n=3) and infected (n=4) BALB/c IL-3 +/+ mice and
analyzed for basophil levels via flow cytometry. (B, C) Dot plots representative of data
from Fig 3.11 A showing PE B220+ and FITC IgE+ cells from bone marrow samples of
uninfected (B) and infected (C) mice. Basophils were considered FITC anti-IgE+ and PE
B220-.
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Figure 13 Basophil levels in LNs from BALB/c IL-3 +/+ mice infected with 1.0x104
L. major metacyclic promastigotes. LN cells were collected at days 4 (A), 9 (B), and 4
weeks (C) post-infection and analyzed via flow cytometry. No IgE+, CD49b+ basophils
were observed in LNs from any mouse at the time points evaluated (n = 3-5).
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Discussion
A limited number of in vitro studies have suggested that IL-3 influences the course of CL,
however, to our knowledge no studies have shown an in vivo role for IL-3 during this disease.
BALB/c WT (IL-3 +/+) and IL-3 deficient (IL-3 -/-) mice were subcutaneously injected
with L. major promastigotes in one ear and the clinical course of infection was monitored for
up to four months. In the absence of IL-3, normally susceptible BALB/c mice infected with
2.0 x 104 metacyclic promastigotes showed less inflammation based on lesion size compared
to BALB/c IL-3 +/+ mice. These differences were especially evident throughout the course
of a 10 week infection (Fig. 4).
Significant differences in infected ear sizes of IL-3 +/+ and IL-3 -/- mice examined at
four weeks post-infection were also noted when mice were infected with smaller parasite
doses (Fig. 6). Likewise, IL-3 -/- mice infected for four months also showed smaller lesions
compared to similarly infected IL-3 +/+ mice (Fig. 7). However, it is important to mention
the mice used in the four month experiment became co-infected with Syphacia obvelata
(mouse pinworms). Lesion sizes among co-infected IL-3 +/+ and IL-3 -/- were not
significantly different (data not shown), likely due to a strong Th2 type immune response
produced by BALB/c mice in order to clear the pin worm infection (72). However, after
pinworm treatment, significant differences in lesions sizes of IL-3 +/+ and IL-3 -/- mice
were seen four months post-infection(Fig 7). No evidence of pinworm infection was
observed with other experiments reported in this study.
Significant differences in lesion sizes among the two genotypes of mice suggest IL-3
operates in vivo during the immune response to Leishmania parasites, a previously unknown
function of this cytokine. Thus, based on measurements of lesion size alone, it appears IL-3
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exacerbates disease. However, a number of reports suggest that lesion size does not
necessarily correlate with the number of parasites present at the inflammatory site (reviewed
by (63)).
The sizes of inflamed lesions that develop during the course of L. major infection can be
attributed to a number of factors. First, lesion size can be influenced by the number of
parasites present at the site of infection, with a higher number of parasites leading to larger
lesions. One could also argue lesion size is regulated by the potency of the host organism’s
immune response. For example, if an organism makes a robust immune response, many
effector cells become activated and migrate to the site of infection where they can initiate
pro-inflammatory activities resulting in increased lesion sizes. Alternatively, weak immune
responses results in fewer or inefficient activation of cells causing less cell migration to the
infection site resulting in smaller lesions. Therefore, observing larger lesions in IL-3 +/+
mice could be caused either by a higher parasite burden or a more robust immune response.
To determine if larger lesions present in IL-3 +/+ mice were caused by a higher parasite
burden, L. major infected IL-3 +/+ and IL-3 -/- mice were sacrificed four weeks postinfection and the parasite load of each individual lesion that developed in the two genotypes
of mice were examined (Fig. 9). This experiment was repeated twice using serial dilutions of
cells from infected ear tissue. Both of these experiments showed IL-3 +/+ mice maintain a
higher parasite burden than similarly infected IL-3 -/- mice indicating their increased lesion
size is likely caused by a higher parasite burden. Higher parasitic loads in IL-3 +/+ mice are
likely caused by an inability to effectively eliminate the parasites suggesting IL-3 may inhibit
leishmaniacidal activities of the immune system. Taken together, the experiments that
examined lesion size and parasite burden suggest that IL-3 is detrimental to the host during
Leishmania infection.
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Protocols for the diagnosis and evaluation of parasite burden have been improved as
research with Leishmania progresses. Traditional protocols call for separation and enzyme
degradation of infected tissues into a single cell suspension. These single cell suspensions are
then serially diluted and incubated with nutrient rich medium which promotes promastigote
growth. Each dilution is monitored for parasites approximately seven to ten days after
plating, and the reciprocal of the highest dilution at which parasites are present is considered
to be the parasite burden. Determining parasite load with such protocols is not accurate
because they only enable an estimate of the true parasite burden. This method only provides
an estimate because the data reported are dilution factors instead of absolute parasite
numbers. Due to the drawbacks inherent with this method, a fairly new protocol utilizing
real-time PCR was performed to validate the data on parasite burden. According to previous
work, this technique is extremely sensitive and can detect minute levels of L. major DNA
equivalent to 0.1 parasites (65). Increased assay sensitivity is ideal, particularly when
attempting to diagnose or quantitate levels of parasites in mildly-infected animals. Therefore,
quantitative PCR was initially employed to determine parasite load in mice infected for four
months (Fig. 10). This experiment was chosen to determine if IL-3 -/- mice that had
seemingly cleared their parasite infection still harbored L. major DNA. These data showed
that IL-3 +/+ mice had markedly higher CT values when compared to IL-3 -/- counterparts
indicating that infected tissue from IL-3 +/+ mice contained more L. major DNA compared
to IL-3 -/- mice Interestingly, two mice from the IL-3 -/- group showed CT values which
were only slightly lower than uninfected ear tissue. Such a high CT value indicates low
amounts of L. major DNA which could be caused by small amounts of viable parasites that
persisted at the site of infection or, alternatively, fragments of DNA from dead parasites that
remained after parasite clearance (73, 74). This is an interesting finding because it may
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suggest in the absence of IL-3, BALB/c mice mount a more protective Th1 response against
Leishmania infection. However, to verify the type of immune response produced by IL-3
+/+ and IL-3 -/- mice, cytokine levels characteristic of those secreted by Th1 and Th2 cells
need to be monitored. Such studies are currently underway in our laboratory. Nevertheless,
these data suggest at least some of the IL-3 -/- mice were able to more effectively combat
the L. major parasites than were IL-3 +/+ mice.
Resistance and susceptibility to L. major infection has been repeatedly shown to be
dependent on the type of adaptive immune response produced by the infected host.
Adaptive immunity, including the development of Th1 and Th2 cells, is typically generated
in lymphoid tissues like LNs. Therefore, draining LNs of infected mice were evaluated to
determine if IL-3 was affecting the local cellular environment. Because LNs provide a venue
for the development of resistant and susceptible immune responses to CL, the differences
observed in disease severity among IL-3 +/+ and IL-3 -/- mice could be explained if IL-3
has the ability to influence the types of cells present in draining LNs. If IL-3 +/+ and
IL-3 -/- mice have different types of cells within their draining LNs, it is highly likely these
cells are producing different types of cytokines, which could in turn influence the type of
immune response.
To test this idea auricular LNs that drained the lesion of L. major-infected IL-3 +/+ and
IL-3 -/- mice were collected at four weeks post-infection and monitored for levels of CD4+
T cells and B cells by flow cytometry. In uninfected IL-3 +/+ and IL-3 -/- mice, the levels
of CD4+ T cells and B cells were essentially identical. However, four weeks after L. major
infection, IL-3 +/+ mice had notably lower percentages of CD4+ T cells and significantly
higher percentages of B cells compared to IL-3 -/- mice (Fig. 11). These findings indicate
IL-3 can either directly, or indirectly, influence the level of lymphocyte populations in
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draining LNs during the course of CL. However, the mechanism by which IL-3 is able to
affect lymphocyte populations is unknown.
Increases in B cell percentages at four weeks post infection by IL-3 +/+ mice suggests B
cell proliferation was induced by some factor(s) at points earlier in infection. Perhaps the
most potent factor which drives antigen-activated B cell proliferation is IL-4. Moreover, IL-4
is the primary cytokine implicated in promoting Th2 immune responses that leads to
susceptibility to Leishmania infection. Therefore, higher numbers of B cells in IL-3 +/+ mice
may indicate there is increased production of IL-4 in infected IL-3 +/+ mice, potentially
resulting in a more polarized Th2 immune response. Since expansion of IL-4-producing
basophils is acutely dependent on IL-3, it would make sense to observe higher levels of IL-4
in IL-3 +/+ mice compared to IL-3 -/- mice. Ongoing experiments in the laboratory are
aimed at assessing IL-4 levels in IL-3 +/+ and IL-3 -/- mice.
In pilot experiments of L. major infection, BALB/c IL-3 +/+ mice had increased disease
severity compared to similarly infected BALB/c IL-3 -/- mice. IL-3 is particularly influential
on basophils; it is the major cytokine that increases the function and proliferation of
basophils in response to infection (59). Increasing the numbers and functional ability of
basophils influences the amount of secretory products (i.e. IL-4) these cells produce.
Therefore, it was hypothesized that increased disease severity seen in Leishmania-infected
IL-3 +/+ mice is caused by IL-3-stimulated basophils promoting Th2 susceptible immune
responses, possibly through their ability to secrete IL-4.
To begin evaluating this hypothesis, it was first determined if L. major infection induced
the expansion of basophil populations in bone marrow which is where basophil
development occurs. At physiological conditions, basophils comprise approximately 0.5 - 0.9
% of bone marrow samples from BALB/c mice (59). Because basophil levels are so low at
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homeostasis, relatively small increases to 2 - 4% would represent significant basophil
proliferation (59) . To monitor the proliferative ability of basophils in response to Leishmania
parasites, bone marrow samples were collected from uninfected and L. major-infected
BALB/c IL-3 +/+ mice and subjected to flow cytometry. IL-3 -/- mice were not initially
evaluated in these studies because IL-3 is the only known factor to promote proliferation of
these cells, and it was assumed that in the absence of IL-3, there would be no basophil
expansion. These studies showed that at five weeks post-infection, basophil levels in bone
marrow from L. major-infected IL-3 +/+ mice were essentially the same as basophil levels
from uninfected IL-3 +/+ mice (Fig. 12). Although no basophil proliferation was detected
at five weeks post infection, this does not conclusively show that basophil populations do
not expand during the course of CL. In fact, basophil populations in bone marrow could
have expanded earlier in response to L. major but had returned to baseline levels by 5 weeks
post-infection. To ensure Leishmania infection does not induce early expansion of basophil
populations, ongoing studies are being completed which look at basophil levels in bone
marrow at earlier time points post-infection.
Basophil levels were also monitored in draining LNs to determine if these cells migrate
to lymphoid tissue in response to L. major infection. Typically, basophils are not detectable in
LNs. However, recent work describing the immune response to nematode infections
reported that basophils transiently migrate to LNs and can influences the type of immune
response by their ability to secrete IL-4 (75). To monitor lymphoid tissue for basophil
migration, L. major-infected IL-3 +/+ mice were sacrificed at days four, nine, and four
weeks post-infection to collect LN cells for flow cytometric analysis. However, no IgE+,
CD49b+ basophils were detected in draining LNs at any of these times following L. major
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infection (Fig. 13). CD49b+ is surface protein expressed by basophils, and together with IgE
staining, is commonly used to distinguish basophils by flow cytometry.
Because basophil were undetectable at the indicated times, these studies suggest that
basophils may not migrate to any significant degree to draining LNs of BALB/c mice in
response to Leishmania infection. However, recent experiments which were able to detect
basophils in LNs suggest basophil migration to LNs is transient (75). Thus, if LNs are not
evaluated at the optimal time, evidence of basophil migration could be missed entirely.
Therefore, it is possible L. major infection does induce basophil migration to LNs but, due to
the transient nature of this migration, we were unable to identify basophils at the specified
time points examined.
Our studies indicate that IL-3 influences the course and outcome of L. major infection in
susceptible BALB/c mice. It was originally hypothesized that susceptibility to Leishmania
parasites would be promoted by IL-3 through its ability to increase basophil numbers.
However, no increases in basophil proliferation were detected in the bone marrow or
draining LNs of

L. major-infected IL-3 +/+ mice, suggesting IL-3 may not induce

basophil proliferation during CL. Although no increases in basophils were observed, the
hypothesis cannot be fully rejected because IL-3 could act by increasing the functional status
of basophils independent of their proliferation. For instance, IL-3 stimulation could result in
elevated IL-4 production by basophils even though basophils remain at approximately
baseline levels. In fact, some studies which indicate that basophils drive Th2 responses have
observed that basophil numbers do not increase during these responses (76).
Experiments which monitor basophil levels in different tissues at multiple times postinfection will be needed in order to rule out the possibility that basophils function during
CL. For example, monitoring bone marrow samples earlier than five weeks following
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infection could rule out the chance that expansion of basophil populations occurs early
during infection and returns to baseline levels by five weeks. Also, basophil levels in LNs
from infected mice could be examined on a day-to-day basis to ensure a transient migration
of these cells to lymphoid tissue is not overlooked. Along with monitoring different time
points following infection, tissues which were not evaluated in the current study, such as
infected ears and blood, should be monitored for basophil increases. If still no basophil
proliferation is noted at these sites and time intervals, the functional ability of these cells
should be evaluated during Leishmania infection. For example, studies could be initiated to
determine if basophils present following L. major infection are able to produce more IL-4
than basophils existing under physiological conditions.
If basophil proliferation and/or function are not increased during CL, IL-3 is likely
functioning independent of basophils. Although the major functions of IL-3 appears to be
its ability to increase the proliferation and secretory ability of basophils, conclusive evidence
regarding the involvement of basophils will require the use of animals selectively deficient in
basophils. If basophils do not have a role in CL, then IL-3 may influence the course and
outcome of Leishmania infection by acting on other cell types known to be influenced by
this cytokine.
IL-3 is known to play a major role in the growth and differentiation of rodent mast cells
(77). IL-3 has also been shown to upregulate mast cell release of mediators like histamine
(78) and anti-inflammatory cytokines such as IL-10 and IL-13 (79). Furthermore, infection
of BALB/c mice with L. major induces significant mast cell degranulation at early stages of
the infection (80), and promotes mast cell proliferation at the site of infection (81). Because
IL-3 is known to influence the development and function of mast cells, and because mast
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cells have been shown to influence the course of Leishmania infection, it is feasible to
speculate that the function of IL-3 during CL could be mast cell dependent.
IL-3 could influence the course and outcome of L. major infection through its role in the
recruitment of effector cells. IL-3 participates in inflammatory responses by inducing the
expression of adhesion molecules on endothelial cells (82, 83). The expression of cell
adhesion molecules by blood vessel endothelial cells near the site of infection facilitates
diapedesis (migration of cells from blood into tissue) of effector cells. In turn, increased
diapedesis would cause higher levels of leukocyte migration to the site of infection resulting
in an advanced degree of inflammation. Therefore, it is possible that IL-3 functions during
CL to promote inflammation through the expression of cell adhesion molecules, which
would explain why higher degrees of inflammation were detected in L. major-infected IL-3
+/+ mice.
Differences seen between L. major-infected IL-3 +/+ and IL-3 -/- mice may also be due
to this cytokine’s ability to influence macrophages. IL-3 has been shown to modulate the
expression of certain molecules on macrophages resulting in different levels of macrophage
activation (84). These cells play such a vital role during CL because amastigotes remain
primarily in macrophages during Leishmania infection. Past studies have monitored the
effects of IL-3 on macrophages in the context of Leishmania infection. For example, Feng et
al. (1988) showed addition of IL-3 to cultured macrophages infected with L. major promoted
the growth of intracellular parasites (42). To further address the role of IL-3 and
macrophages, Saha et al. (1999) examined leishmanial-antigen pulsed macrophages derived in
vitro with either IL-3 or GM-CSF that were adoptively transferred into BALB/c mice just
prior to infection with L. major. While BALB/c mice receiving GM-CSF-derived
macrophages significantly resist infection, BALB/c mice receiving IL-3-derived
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macrophages exacerbated disease as assessed by footpad thickness (43). Currently, in vivo
experiments are being conducted to determine the effects of IL-3 on macrophage function
during CL. These studies are focused on the activational status of macrophages at the site of
L. major inoculation to determine if endogenous IL-3 does in fact induce anti-leishmaniacidal
effects.
This study has established a novel finding which shows that endogenous IL-3
significantly contributes to the susceptibility of BALB/c mice during L. major infection. This
is supported by data showing that L. major-infected IL-3 +/+ mice have increased
inflammatory lesions and increased parasite burdens relative to similarly infected IL-3 -/mice. That IL-3 may function in CL to promote a Th2-dominated immune response is
supported by our data that shows infected IL-3 +/+ mice have increased levels of B cells
and decreased of CD4+ T cells. Although these studies indicate that basophil numbers do
not increase during infection at the time points examined, these data do not rule out the
possibility that physiological levels of IL-3-dependent basophils influence the immune
response. Because IL-3 can influence cellular differentiation, and expression of molecules by
a number of different cell lineages, several possibilities could explain how IL-3 functions
during CL. It is unlikely that the function of IL-3 during this disease can be completely
explained by its effects on a single population of cells. Instead the differences observed in
IL-3 +/+ and IL-3 -/- are likely caused by IL-3 acting on numerous cell types in a concerted
fashion. Although the mechanism(s) by which endogenous IL-3 functions during CL has yet
to be fully determined, the current study has established an important and novel finding
regarding the immune response to CL. Furthermore, the current work justifies further
examination of the role of IL-3 in CL and will reveal new insights on the role of IL-3 in
health and disease.
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Appendix
The following figures have been added for further clarification and are intended to
supplement both the materials and methods and the results sections.
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Figure 14 Genotyping IL-3 +/+ and IL-3 -/- mice. Constructs used to produce IL-3 -/mice allow the genotypes to be distinguished by PCR. Using specific primers permits the
amplification of DNA fragments which are different sizes and correspond to either
IL-3 +/+ (1200bp) or IL-3 -/- (800bp) mouse DNA. Tail biopsies were collected from
both groups of mice and DNA was extracted by enzyme degradation and subjected to
PCR. After PCR, DNA products were then run on an agarose gel and stained with
ethidium bromide to detect amplicons.
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Figure 15 Images of L. major parasites in culture at different developmental stages.
Cytospins of L. major culture samples were fixed and stained with Giemsa for 15 min.
Plates A, B, and C represent images of parasites taken at days 2, 3, and 4, respectively.
Plate D represents purified metacyclic promastigotes isolated from culture on day 5 by
negative selection via peanut agglutinin. Metacyclic parasites display a homogeneous
morphology and can be distinguished from less mature promastigotes based on their
slender cell body, long flagellum, and tapered anterior tip. In each plate, scale bars
represent 10 m.
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Figure 16 Leishmania major growth curve. L. major parasites were cultured in c-M199
media for 5 days to facilitate the development of infective stage metacyclic promastigotes.
Metacyclics were then separated from the rest of the culture to initiate infections via
negative selection with PNA. Data represents total number of parasites (left y axis) each
day after initiating the culture, and the total number of metacyclic promastigotes (right y
axis) isolated on day 5 of culture.
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Figure 17 L. major metacyclic promastigotes being injected into the ear dermis of an
anesthetized mouse.
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Figure 18 Image of L. major-infected and PBS-injected mouse ears. (A) PBS-injected
mouse ear showing no pathology or visually detectable inflammation. (B) L. majorinfected ear showing distinct lesion and inflammation at site of infection.
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